Studies confirm value of IL-2/LAK treatment.
Wittenberg
C
C
D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology*; D008545:Melanoma / Q000556:secondary / Q000628:therapy*; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000628:therapy*
D007376:Interleukin-2